Pathogenesis of non-antibody mediated transfusion-related acute lung injury from bench to bedside

Blood Reviews

Volumn 29, Issue 1, 2015, Pages 51-61

  Peters, Anna L ^a   van Hezel, Maike E ^a   Juffermans, Nicole P ^a   Vlaar, Alexander P J ^a  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

Duffy antigen; Heme; LysoPCs; Microparticles; Non transferrin bound iron; Platelets; Red blood cells; SCD40L; Storage; TRALI; Transfusion

Indexed keywords

CD40 LIGAND; LIPID; LYSOPHOSPHATIDYLCHOLINE;

BLOOD FILTRATION; CAUSAL ATTRIBUTION; CELL AGING; CELL FUNCTION; ERYTHROCYTE ADHESIVENESS; ERYTHROCYTE DEFORMABILITY; ERYTHROCYTE PRESERVATION; ERYTHROCYTE STRUCTURE; HUMAN; IRON METABOLISM; LIPID ANALYSIS; NONHUMAN; OXYGEN THERAPY; PATHOGENESIS; PLATELET MICROPARTICLE; PREVENTIVE MEDICINE; PRODUCT PARAMETERS; REVIEW; STORAGE TIME; THROMBOCYTE PRESERVATION; THROMBOCYTE STRUCTURE; TRANSFUSION RELATED ACUTE LUNG INJURY; ACUTE LUNG INJURY; ADVERSE EFFECTS; ANIMAL; BLOOD TRANSFUSION; TRANSLATIONAL RESEARCH;

ACUTE LUNG INJURY; ANIMALS; BLOOD TRANSFUSION; HUMANS; TRANSLATIONAL MEDICAL RESEARCH;

EID: 84921737638     PISSN: 0268960X     EISSN: 15321681     Source Type: Journal    
DOI: 10.1016/j.blre.2014.09.007     Document Type: Article

References (129)

1. Stainsby D., Jones H., Asher D., Atterbury C., Boncinelli A., Brant L., et al. Serious hazards of transfusion: a decade of hemovigilance in the UK. Transfus Med Rev 2006, 20:273-282.
2. Kleinman S. A perspective on transfusion-related acute lung injury two years after the Canadian Consensus Conference. Transfusion 2006, 46:1465-1468.
3. Goldman M., Webert K.E., Arnold D.M., Freedman J., Hannon J., Blajchman M.A. Proceedings of a Consensus Conference: towards an Understanding of TRALI. Transfus Med Rev 2005, 19:2-31.
4. Holness L., Knippen M.A., Simmons L., Lachenbruch P.A. Fatalities caused by TRALI. Transfus Med Rev 2004, 18:184-188.
5. Toy P., Popovsky M.A., Abraham E., Daniel R., Ambruso D.R., Holness L.G., et al. Transfusion-related acute lung injury: definition and review. Crit Care Med 2005, 33:721-726.
6. Ausley M.B. Fatal transfusion reactions caused by donor antibodies to recipient leukocytes. Am J Forensic Med Pathol 1987, 8:287-290.
7. Silliman C.C., Bjornsen A.J., Wyman T.H., Kelher M., Allard J., Bieber S., et al. Plasma and lipids from stored platelets cause acute lung injury in an animal model. Transfusion 2003, 43:633-640.
8. Gajic O., Rana R., Winters J.L., Yilmaz M., Mendez J.L., Rickman O.B., et al. Transfusion-related acute lung injury in the critically ill: prospective nested case-control study. Am J Respir Crit Care Med 2007, 176:886-891.
9. Vlaar A.P., Juffermans N.P. Transfusion-related acute lung injury: a clinical review. Lancet 2013, 382:984-994.
10. Rana R., Fernandez-Perez E.R., Khan S.A., Rana S., Winters J.L., Lesnick T.G., et al. Transfusion-related acute lung injury and pulmonary edema in critically ill patients: a retrospective study. Transfusion 2006, 46:1478-1483.
11. Silliman C.C., Boshkov L.K., Mehdizadehkashi Z., Elzi D.J., Dickey W.O., Podlosky L., et al. Transfusion-related acute lung injury: epidemiology and a prospective analysis of etiologic factors. Blood 2003, 101:454-462.
12. Toy P., Gajic O., Bacchetti P., Looney M.R., Gropper M.A., Hubmayr R., et al. Transfusion-related acute lung injury: incidence and risk factors. Blood 2012, 119:1757-1767.
13. Vlaar A.P., Binnekade J.M., Prins D., van Stein D., Hofstra J.J., Schultz M.J., et al. Risk factors and outcome of transfusion-related acute lung injury in the critically ill: a nested case-control study. Crit Care Med 2010, 38:771-778.
14. Vlaar A.P., Hofstra J.J., Determann R.M., Veelo D.P., Paulus F., Kulik W., et al. The incidence, risk factors, and outcome of transfusion-related acute lung injury in a cohort of cardiac surgery patients: a prospective nested case-control study. Blood 2011, 117:4218-4225.
15. Bux J., Becker F., Seeger W., Kilpatrick D., Chapman J., Waters A. Transfusion-related acute lung injury due to HLA-A2-specific antibodies in recipient and NB1-specific antibodies in donor blood. Br J Haematol 1996, 93:707-713.
16. Kakaiya R.M., Triulzi D.J., Wright D.J., Steele W.R., Kleinman S.H., Busch M.P., et al. Prevalence of HLA antibodies in remotely transfused or alloexposed volunteer blood donors. Transfusion 2010, 50:1328-1334.
17. Gans R.O.B., Duurkens V.A.M., Vanzundert A.A., Hoorntje S.J. Transfusion-related acute lung injury. Intensive Care Med 1988, 14:654-657.
18. Silliman C.C., Paterson A.J., Dickey W.O., Stroneck D.F., Popovsky M.A., Caldwell S.A., et al. The association of biologically active lipids with the development of transfusion-related acute lung injury: a retrospective study. Transfusion 1997, 37:719-726.
19. Toy P., Hollis-Perry K.M., Jun J., Nakagawa M. Recipients of blood from a donor with multiple HLA antibodies: a lookback study of transfusion-related acute lung injury. Transfusion 2004, 44:1683-1688.
20. Kopko P.M., Marshall C.S., MacKenzie M.R., Holland P.V., Popovsky M.A. Transfusion-related acute lung injury: report of a clinical look-back investigation. JAMA 2002, 287:1968-1971.
21. Li G., Kojicic M., Reriani M.K., Fernandez Perez E.R., Thakur L., Kashyap R., et al. Long-term survival and quality of life after transfusion-associated pulmonary edema in critically ill medical patients. Chest 2010, 137:783-789.
22. Vlaar A.P. Transfusion-related acute lung injury: current understanding and preventive strategies. Transfus Clin Biol 2012, 19:117-124.
23. Kelher M.R., Masuno T., Moore E.E., Damle S., Meng X., Song Y., et al. Plasma from stored packed red blood cells and MHC class I antibodies causes acute lung injury in a 2-event in vivo rat model. Blood 2009, 113:2079-2087.
24. Silliman C.C., Kelher M. The role of endothelial activation in the pathogenesis of transfusion-related acute lung injury. Transfusion 2005, 45:109S-116S.
25. Silliman C.C. The two-event model of transfusion-related acute lung injury. Crit Care Med 2006, 34:S124-S131.
26. Finlayson J., Grey D., Kavanagh L., Witt C. Transfusion-related acute lung injury in a neutropenic patient. J Intern Med 2011, 41:638-641.
27. Danielson C., Benjamin R.J., Mangano M.M., Mills C.J., Waxman D.A. Pulmonary pathology of rapidly fatal transfusion-related acute lung injury reveals minimal evidence of diffuse alveolar damage or alveolar granulocyte infiltration. Transfusion 2008, 48:2401-2408.
28. Middelburg R.A., Borkent-Raven B.A., Janssen M.P., van de Watering L.M., Wiersum-Osselton J.C., Schipperus M.R., et al. Storage time of blood products and transfusion-related acute lung injury. Transfusion 2012, 52:658-667.
29. Li S.D., Su Y.D., Li M., Zou C.G. Hemin-mediated hemolysis in erythrocytes: effects of ascorbic acid and glutathione. Acta Biochim Biophys Sin (Shanghai) 2006, 38:63-69.
30. Brinkmann V., Reichard U., Goosmann C., Fauler B., Uhlemann Y., Weiss D.S., et al. Neutrophil extracellular traps kill bacteria. Science 2004, 303:1532-1535.
31. Savchenko A.S., Inoue A., Ohashi R., Jiang S., Hasegawa G., Tanaka T., et al. Long pentraxin 3 (PTX3) expression and release by neutrophils in vitro and in ulcerative colitis. Pathol Int 2011, 61:290-297.
32. Kessenbrock K., Krumbholz M., Schonermarck U., Back W., Gross W.L., Werb Z., et al. Netting neutrophils in autoimmune small-vessel vasculitis. Nat Med 2009, 15:623-625.
33. Gupta A.K., Hasler P., Holzgreve W., Gebhardt S., Hahn S. Induction of neutrophil extracellular DNA lattices by placental microparticles and IL-8 and their presence in preeclampsia. Hum Immunol 2005, 66:1146-1154.
34. Thomas G.M., Carbo C., Curtis B.R., Martinod K., Mazo I.B., Schatzberg D., et al. Extracellular DNA traps are associated with the pathogenesis of TRALI in humans and mice. Blood 2012, 119:6335-6343.
35. Caudrillier A., Kessenbrock K., Gilliss B.M., Nguyen J.X., Marques M.B., Monestier M., et al. Platelets induce neutrophil extracellular traps in transfusion-related acute lung injury. J Clin Invest 2012, 122:2661-2671.
36. Kono M., Saigo K., Takagi Y., Kawauchi S., Wada A., Hashimoto M., et al. Morphological and flow-cytometric analysis of haemin-induced human neutrophil activation: implications for transfusion-related acute lung injury. Blood Transfus 2013, 11:53-60.
37. Kono M., Saigo K., Takagi Y., Takahashi T., Kawauchi S., Wada A., et al. Heme-related molecules induce rapid production of neutrophil extracellular traps. Transfusion May 28 2014, [Epub ahead of print]. 10.1111/trf.12700.
38. Tinmouth A., Fergusson D., Yee I.C., Hebert P.C., Investigators A., Canadian Critical Care Trials G Clinical consequences of red cell storage in the critically ill. Transfusion 2006, 46:2014-2027.
39. Ohto H., Nollet K.E. Overview on platelet preservation: better controls over storage lesion. Transfus Apher Sci 2011, 44:321-325.
40. Hess J.R. Measures of stored red blood cell quality. Vox Sang 2014, 107:1-9.
41. Marik P.E., Corwin H.L. Efficacy of red blood cell transfusion in the critically ill: a systematic review of the literature. Crit Care Med 2008, 36:2667-2674.
42. Patel S.V., Kidane B., Klingel M., Parry N. Risks associated with red blood cell transfusion in the trauma population, a meta-analysis. Injury May 24 2014, [pii: S0020-1383(14)00254-X. [Epub ahead of print]]. 10.1016/j.injury.2014.05.015.
43. van Straten A.H., Soliman Hamad M.A., Martens E.J., Tan M.E., de Wolf A.M., Scharnhorst V., et al. Effect of storage time of transfused plasma on early and late mortality after coronary artery bypass grafting. J Thorac Cardiovasc Surg 2011, 141(238-43):e1-e2.
44. van der Bom J.G., Middelburg R.A., van de Watering L.M., Brand A. Comment on "Effect of storage time of transfused plasma on early and late mortality after coronary artery bypass grafting". J Thorac Cardiovasc Surg 2011, 142:473-474.
45. Silliman C.C., Kelher M.R., Khan S.Y., Lasarre M., West F.B., Land K.J., et al. Experimental pre-storage filtration removes antibodies and decreases lipid bioactivity accumulation in RBC supernatants mitigating TRALI in an animal model. Blood 2014, 123:3488-3495.
46. Silliman C.C., Voelkel N.F., Allard J.D., Elzi D.J., Tuder R.M., Johnson J.L., et al. Plasma and lipids from stored packed red blood cells cause acute lung injury in an animal model. J Clin Invest 1998, 101:1458-1467.
47. Vlaar A.P., Hofstra J.J., Kulik W., van Lenthe H., Nieuwland R., Schultz M.J., et al. Supernatant of stored platelets causes lung inflammation and coagulopathy in a novel in vivo transfusion model. Blood 2010, 116:1360-1368.
48. Vlaar A.P., Hofstra J.J., Levi M., Kulik W., Nieuwland R., Tool A.T., et al. Supernatant of aged erythrocytes causes lung inflammation and coagulopathy in a "two-hit" in vivo syngeneic transfusion model. Anesthesiology 2010, 113:92-103.
49. Wyman T.H., Bjornsen A.J., Elzi D.J., Smith C.W., England K.M., Kelher M., et al. A two-insult in vitro model of PMN-mediated pulmonary endothelial damage: requirements for adherence and chemokine release. Am J Physiol Cell Physiol 2002, 283:C1592-C1603.
50. Silliman C.C., Dickey W.O., Paterson A.J., Thurman G.W., Clay K.L., Johnson C.A., et al. Analysis of the priming activity of lipids generated during routine storage of platelet concentrates. Transfusion 1996, 36:133-139.
51. Khan S.Y., McLaughlin N.J., Kelher M.R., Eckels P., Gamboni-Robertson F., Banerjee A., et al. Lysophosphatidylcholines activate G2A inducing G(alphai)(-)(1)-/G(alphaq/)(1)(1)-Ca(2)(+) flux, G(betagamma)-Hck activation and clathrin/beta-arrestin-1/GRK6 recruitment in PMNs. Biochem J 2010, 432:35-45.
52. Carlos T.M., Harlan J.M. Leukocyte-endothelial adhesion molecules. Blood 1994, 84:2068-2101.
53. Silliman C.C., Moore E.E., Kelher M.R., Khan S.Y., Gellar L., Elzi D.J. Identification of lipids that accumulate during the routine storage of prestorage leukoreduced red blood cells and cause acute lung injury. Transfusion 2011, 51:2549-2554.
54. Maslanka K., Smolenska-Sym G., Michur H., Wrobel A., Lachert E., Brojer E. Lysophosphatidylcholines: bioactive lipids generated during storage of blood components. Arch Immunol Ther Exp (Warsz) 2012, 60:55-60.
55. Sachs U.J., Weissmann N., Wasel W., Bein G., Berghöfer H., Schilow W., et al. Supernatants from stored leukodepleted packed red blood cells do not regularly exhibit changes in their (lyso-) phosphatidylcholine composition and do not cause TRALI in an ex vivo rat lung model. Vox Sang 2010, 99(Suppl. s1):456.
56. Adawi A., Zhang Y., Baggs R., Finkelstein J., Phipps R.P. Disruption of the CD40-CD40 ligand system prevents an oxygen-induced respiratory distress syndrome. Am J Pathol 1998, 152:651-657.
57. Vlaar A.P.J., Kulik W., Nieuwland R., Peters C.P., Tool A.T.J., van Bruggen R., et al. Accumulation of bioactive lipids during storage of blood products is not cell but plasma derived and temperature dependent. Transfusion 2011, 51:2358-2366.
58. Inwald D.P., McDowall A., Peters M.J., Callard R.E., Klein N.J. CD40 is constitutively expressed on platelets and provides a novel mechanism for platelet activation. Circ Res 2003, 92:1041-1048.
59. Khan S.Y., Kelher M.R., Heal J.M., Blumberg N., Boshkov L.K., Phipps R., et al. Soluble CD40 ligand accumulates in stored blood components, primes neutrophils through CD40, and is a potential cofactor in the development of transfusion-related acute lung injury. Blood 2006, 108:2455-2462.
60. Wenzel F., Gunther W., Baertl A., Lasshofer R., Rox J., Fischer J.C., et al. Comparison of soluble CD40L concentrations and release capacities in apheresis and prestorage pooled platelet concentrates. Clin Hemorheol Microcirc 2011, 47:269-278.
61. Blumberg N., Gettings K.F., Turner C., Heal J.M., Phipps R.P. An association of soluble CD40 ligand (CD154) with adverse reactions to platelet transfusions. Transfusion 2006, 46:1813-1821.
62. Xie R.F., Hu P., Li W., Ren Y.N., Yang J., Yang Y.M., et al. The effect of platelet-derived microparticles in stored apheresis platelet concentrates on polymorphonuclear leucocyte respiratory burst. Vox Sang 2013, 106:234-241.
63. Hashimoto N., Kawabe T., Imaizumi K., Hara T., Okamoto M., Kojima K., et al. CD40 plays a crucial role in lipopolysaccharide-induced acute lung injury. Am J Respir Cell Mol Biol 2004, 30:808-815.
64. Tung J.P., Fraser J.F., Nataatmadja M., Colebourne K.I., Barnett A.G., Glenister K.M., et al. Age of blood and recipient factors determine the severity of transfusion-related acute lung injury (TRALI). Crit Care 2012, 16:R19.
65. Tuinman P.R., Gerards M.C., Jongsma G., Vlaar A.P., Boon L., Juffermans N.P. Lack of evidence of CD40 ligand involvement in transfusion-related acute lung injury. Clin Exp Immunol 2011, 165:278-284.
66. Vlaar A.P., Straat M., Juffermans N.P. The relation between aged blood products and onset of transfusion-related acute lung injury. A review of pre-clinical data. Clin Lab 2011, 57:267-272.
67. Darbonne W.C., Rice G.C., Mohler M.A., Apple T., Hebert C.A., Valente A.J., et al. Red blood cells are a sink for interleukin 8, a leukocyte chemotaxin. J Clin Invest 1991, 88:1362-1369.
68. Mangalmurti N.S., Xiong Z., Hulver M., Ranganathan M., Liu X.H., Oriss T., et al. Loss of red cell chemokine scavenging promotes transfusion-related lung inflammation. Blood 2009, 113:1158-1166.
69. Leytin V., Freedman J. Platelet apoptosis in stored platelet concentrates and other models. Transfus Apher Sci 2003, 28:285-295.
70. Seghatchian J., de Sousa G. Pathogen-reduction systems for blood components: the current position and future trends. Transfus Apher Sci 2006, 35:189-196.
71. Gelderman M.P., Chi X., Zhi L., Vostal J.G. Ultraviolet B light-exposed human platelets mediate acute lung injury in a two-event mouse model of transfusion. Transfusion 2011, 51:2343-2357.
72. Silliman C.C., Khan S.Y., Ball J.B., Kelher M.R., Marschner S. Mirasol Pathogen Reduction Technology treatment does not affect acute lung injury in a two-event in vivo model caused by stored blood components. Vox Sang 2010, 98:525-530.
73. Zhi L., Chi X., Gelderman M.P., Vostal J.G. Activation of platelet protein kinase C by ultraviolet light B mediates platelet transfusion-related acute lung injury in a two-event animal model. Transfusion 2013, 53:722-731.
74. Chi X., Zhi L., Gelderman M.P., Vostal J.G. Host platelets and, in part, neutrophils mediate lung accumulation of transfused UVB-irradiated human platelets in a mouse model of acute lung injury. PLoS ONE 2012, 7:e44829.
75. Harr J.N., Moore E.E., Wohlauer M.V., Fragoso M., Gamboni F., Liang X., et al. Activated platelets in heparinized shed blood: the "second hit" of acute lung injury in trauma/hemorrhagic shock models. Shock 2011, 36:595-603.
76. Chi X., Zhi L., Vostal J.G. Human platelets pathogen reduced with riboflavin and ultraviolet light do not cause acute lung injury in a two-event SCID mouse model. Transfusion 2014, 54:74-85.
77. Tuinman P.R., Vlaar A.P., Binnenkade J.M., Juffermans N.P. The effect of aspirin in transfusion-related acute lung injury in critically ill patients. Anaesthesia 2012, 67:594-599.
78. Lacroix J., Hebert P., Fergusson D., Tinmouth A., Blajchman M.A., Callum J., et al. The Age of Blood Evaluation (ABLE) randomized controlled trial: study design. Transfus Med Rev 2011, 25:197-205.
79. Steiner M.E., Assmann S.F., Levy J.H., Marshall J., Pulkrabek S., Sloan S.R., et al. Addressing the question of the effect of RBC storage on clinical outcomes: the Red Cell Storage Duration Study (RECESS) (Section 7). Transfus Apher Sci 2010, 43:107-116.
80. Koch CG. Red cell storage duration and outcomes in cardiac surgery. Clinical Trials Identifier Gov: NCT00458783.
81. STandaRd Issue TrANsfusion versuS Fresher red blood cell Use in intenSive carE - a randomised controlled trial. Chief Investigator: Prof Jamie Cooper 2013, The Australian & New Zealand Intensive Care Research Centre.
82. Barshtein G., Manny N., Yedgar S. Circulatory risk in the transfusion of red blood cells with impaired flow properties induced by storage. Transfus Med Rev 2011, 25:24-35.
83. Anniss A.M., Sparrow R.L. Variable adhesion of different red blood cell products to activated vascular endothelium under flow conditions. Am J Hematol 2007, 82:439-445.
84. Eichelbronner O., Sielenkamper A., Cepinskas G., Sibbald W.J., Chin-Yee I.H. Endotoxin promotes adhesion of human erythrocytes to human vascular endothelial cells under conditions of flow. Crit Care Med 2000, 28:1865-1870.
85. Hess J.R. Red cell storage. J Proteome 2010, 73:368-373.
86. Jy W., Ricci M., Shariatmadar S., Gomez-Marin O., Horstman L.H., Ahn Y.S. Microparticles in stored red blood cells as potential mediators of transfusion complications. Transfusion 2011, 51:886-893.
87. Luten M., Roerdinkholder-Stoelwinder B., Schaap N.P., de Grip W.J., Bos H.J., Bosman G.J. Survival of red blood cells after transfusion: a comparison between red cells concentrates of different storage periods. Transfusion 2008, 48:1478-1485.
88. Ozment C.P., Turi J.L. Iron overload following red blood cell transfusion and its impact on disease severity. Biochim Biophys Acta 2009, 1790:694-701.
89. Hod E.A., Zhang N., Sokol S.A., Wojczyk B.S., Francis R.O., Ansaldi D., et al. Transfusion of red blood cells after prolonged storage produces harmful effects that are mediated by iron and inflammation. Blood 2010, 115:4284-4292.
90. Hod E.A., Brittenham G.M., Billote G.B., Francis R.O., Ginzburg Y.Z., Hendrickson J.E., et al. Transfusion of human volunteers with older, stored red blood cells produces extravascular hemolysis and circulating non-transferrin-bound iron. Blood 2011, 118:6675-6682.
91. Mause S.F., Weber C. Microparticles: protagonists of a novel communication network for intercellular information exchange. Circ Res 2010, 107:1047-1057.
92. Rubin O., Crettaz D., Tissot J.D., Lion N. Microparticles in stored red blood cells: submicron clotting bombs?. Blood Transfus 2010, 8(Suppl. 3):s31-s38.
93. Simak J., Gelderman M.P. Cell membrane microparticles in blood and blood products: potentially pathogenic agents and diagnostic markers. Transfus Med Rev 2006, 20:1-26.
94. McVey M., Tabuchi A., Kuebler W.M. Microparticles and acute lung injury. Am J Physiol Lung Cell Mol Physiol 2012, 303:L364-L381.
95. Kriebardis A.G., Antonelou M.H., Stamoulis K.E., Economou-Petersen E., Margaritis L.H., Papassideri I.S. RBC-derived vesicles during storage: ultrastructure, protein composition, oxidation, and signaling components. Transfusion 2008, 48:1943-1953.
96. Xiong Z., Cavaretta J., Qu L., Stolz D.B., Triulzi D., Lee J.S. Red blood cell microparticles show altered inflammatory chemokine binding and release ligand upon interaction with platelets. Transfusion 2011, 51:610-621.
97. Rubin O., Crettaz D., Canellini G., Tissot J.D., Lion N. Microparticles in stored red blood cells: an approach using flow cytometry and proteomic tools. Vox Sang 2008, 95:288-297.
98. Belizaire R.M., Prakash P.S., Richter J.R., Robinson B.R., Edwards M.J., Caldwell C.C., et al. Microparticles from stored red blood cells activate neutrophils and cause lung injury after hemorrhage and resuscitation. J Am Coll Surg 2012, 214:648-655. [discussion 56-7].
99. Cardo L.J., Wilder D., Salata J. Neutrophil priming, caused by cell membranes and microvesicles in packed red blood cell units, is abrogated by leukocyte depletion at collection. Transfus Apher Sci 2008, 38:117-125.
100. Bosman G.J., Lasonder E., Luten M., Roerdinkholder-Stoelwinder B., Novotny V.M., Bos H., et al. The proteome of red cell membranes and vesicles during storage in blood bank conditions. Transfusion 2008, 48:827-835.
101. Morel O., Morel N., Jesel L., Freyssinet J.M., Toti F. Microparticles: a critical component in the nexus between inflammation, immunity, and thrombosis. Semin Immunopathol 2011, 33:469-486.
102. Lechner D., Weltermann A. Circulating tissue factor-exposing microparticles. Thromb Res 2008, 122(Suppl. 1):S47-S54.
103. van der Poll T. Tissue factor as an initiator of coagulation and inflammation in the lung. Crit Care 2008, 12(Suppl. 6):S3.
104. Mackman N. Role of tissue factor in hemostasis and thrombosis. Blood Cells Mol Dis 2006, 36:104-107.
105. Sinauridze E.I., Kireev D.A., Popenko N.Y., Pichugin A.V., Panteleev M.A., Krymskaya O.V., et al. Platelet microparticle membranes have 50- to 100-fold higher specific procoagulant activity than activated platelets. Thromb Haemost 2007, 97:425-434.
106. Sugawara A., Nollet K.E., Yajima K., Saito S., Ohto H. Preventing platelet-derived microparticle formation - and possible side effects - with prestorage leukofiltration of whole blood. Arch Pathol Lab Med 2010, 134:771-775.
107. Antonelou M.H., Kriebardis A.G., Stamoulis K.E., Economou-Petersen E., Margaritis L.H., Papassideri I.S. Red blood cell aging markers during storage in citrate-phosphate-dextrose-saline-adenine-glucose-mannitol. Transfusion 2010, 50:376-389.
108. Bennett-Guerrero E., Kirby B.S., Zhu H., Herman A.E., Bandarenko N., McMahon T.J. Randomized study of washing 40- to 42-day-stored red blood cells. Transfusion Apr 2014, 16. [Epub ahead of print]. 10.1111/trf.12660.
109. Masalunga C., Cruz M., Porter B., Roseff S., Chui B., Mainali E. Increased hemolysis from saline pre-washing RBCs or centrifugal pumps in neonatal ECMO. J Perinatol 2007, 27:380-384.
110. Gruber M., Breu A., Frauendorf M., Seyfried T., Hansen E. Washing of banked blood by three different blood salvage devices. Transfusion 2013, 53:1001-1009.
111. Smith T., Riley W., Fitzgerald D. In vitro comparison of two different methods of cell washing. Perfusion 2013, 28:34-37.
112. Jilma-Stohlawetz P., Eichelberger B., List J., Jilma B., Panzer S., Leitner G. The effect of plasma removal from apheresis platelet concentrates on platelet function. Vox Sang 2012, 102:258-260.
113. Karafin M., Fuller A.K., Savage W.J., King K.E., Ness P.M., Tobian A.A. The impact of apheresis platelet manipulation on corrected count increment. Transfusion 2012, 52:1221-1227.
114. Blumberg N., Heal J.M., Gettings K.F., Phipps R.P., Masel D., Refaai M.A., et al. An association between decreased cardiopulmonary complications (transfusion-related acute lung injury and transfusion-associated circulatory overload) and implementation of universal leukoreduction of blood transfusions. Transfusion 2010, 50:2738-2744.
115. de Vroege R., Wildevuur W.R., Muradin J.A., Graves D., van Oeveren W. Washing of stored red blood cells by an autotransfusion device before transfusion. Vox Sang 2007, 92:130-135.
116. Bilgin Y.M., van de Watering L.M., Brand A. Clinical effects of leucoreduction of blood transfusions. Neth J Med 2011, 69:441-450.
117. Sowemimo-Coker S.O. Evaluation of an experimental filter designed for improving the quality of red blood cells (RBCs) during storage by simultaneously removing white blood cells and immunomodulators and improving RBC viscoelasticity and Band 3 proteins. Transfusion 2014, 54:592-601.
118. Wang D., Sun J., Solomon S.B., Klein H.G., Natanson C. Transfusion of older stored blood and risk of death: a meta-analysis. Transfusion 2012, 52:1184-1195.
119. Lelubre C., Vincent J.L. Relationship between red cell storage duration and outcomes in adults receiving red cell transfusions: a systematic review. Crit Care 2013, 17:R66.
120. Wallis J.P., Lubenko A., Wells A.W., Chapman C.E. Single hospital experience of TRALI. Transfusion 2003, 43:1053-1059.
121. Moore S.B. Transfusion-related acute lung injury (TRALI): clinical presentation, treatment, and prognosis. Crit Care Med 2006, 34:S114-S117.
122. Popovsky M.A. Transfusion and lung injury. Transfus Clin Biol 2001, 8:272-277.
123. Looney M.R., Roubinian N., Gajic O., Gropper M.A., Hubmayr R.D., Lowell C.A., et al. Prospective study on the clinical course and outcomes in transfusion-related acute lung injury*. Crit Care Med 2014, 42:1676-1687.
124. Bennett S.H., Geelhoed G.W., Aaron R.K., Solis R.T., Hoye R.C. Pulmonary injury resulting from perfusion with stored bank blood in the baboon and dog. J Surg Res 1972, 13:295-306.
125. Bennett S.H., Geelhoed G.W., Terrill R.E., Hoye R.C. Pulmonary effects of autotransfused blood. A comparison of fresh autologous and stored blood with blood retrieved from the pleural cavity in an in situ lung perfusion model. Am J Surg 1973, 125:696-702.
126. Nicholson S.E., Johnson R.A., Craig T., Myers J.G., Durante W., Stewart R.M., et al. Transfusion-related acute lung injury in a rat model of trauma-hemorrhage. J Trauma 2011, 70:466-471.
127. Fung Y.L., Tung J.P., Foley S.R., Simonova G., Thom O., Staib A., et al. Stored blood transfusion induces transient pulmonary arterial hypertension without impairing coagulation in an ovine model of nontraumatic haemorrhage. Vox Sang 2013, 105:150-158.
128. Tung J.P., Fung Y.L., Nataatmadja M., Colebourne K.I., Esmaeel H.M., Wilson K., et al. A novel in vivo ovine model of transfusion-related acute lung injury (TRALI). Vox Sang 2011, 100:219-230.
129. Zhi L., Chi X., Vostal J.G. In vitro and in vivo characterization of ultraviolet light C-irradiated human platelets in a 2 event mouse model of transfusion. PLoS ONE 2013, 8:e79869.